Persistence and Reasons for Discontinuation of Subcutaneous Immunotherapy in Children with Dust Mite Allergy: A Real-World Cohort from Hangzhou, China
Zhenghong Song, Jing He, Shuxian Li, Kaiyi Lu, Hanqing Shao, Jinling Liu, Lei Wu, Hongzhen Xu, Zhimin Chen · 2026
Read Persistence and Reasons for Discontinuation of Subcutaneous Immunotherapy in Children with Dust Mite Allergy: A Real-World Cohort from Hangzhou, China by Zhenghong Song, Jing He, Shuxian Li, Kaiyi Lu, Hanqing Shao, Jinling Liu, Lei Wu, Hongzhen Xu, Zhimin Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13155399.txt.
Description
Song and eight co-authors studied why children quit allergy shots for dust mite allergy in Hangzhou, China, in twenty twenty-six. Subcutaneous immunotherapy injects small allergen doses over at least three years to retrain the immune system. Many families stop early, weakening the benefit.
Records from twenty seventeen to twenty twenty-three covered six hundred eighty children with allergic asthma, rhinitis, or related disease. About sixty-two percent finished the full course; thirty-eight percent quit early. Doubts about efficacy were the top reason overall, then drug intolerance and family factors. Timing mattered: family issues dominated the first month, intolerance the first six months, and efficacy doubts later. The authors urge better parent education, standard protocols, and quick handling of side effects.
Catalog record
| CREATOR | Zhenghong Song, Jing He, Shuxian Li, Kaiyi Lu, Hanqing Shao, Jinling Liu, Lei Wu, Hongzhen Xu, Zhimin Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |